Status:
COMPLETED
A Prospective Multicenter Study to Evaluate Usefulness of Cardio-Ankle Vascular Index in Japan
Lead Sponsor:
CAVI-J Study Group
Collaborating Sponsors:
Toho University
Ehime University Graduate School of Medicine
Conditions:
Stroke
Cardiovascular Death
Eligibility:
All Genders
40-74 years
Brief Summary
The objective of this five-year prospective observational follow-up study is to examine the additional benefits of using cardio-ankle vascular index (CAVI) as a predictive indicator of cardiovascular ...
Eligibility Criteria
Inclusion
- Patients between 40 and 74 years of age who have either of the following:
- Type 2 diabetes mellitus
- Metabolic syndrome
- Grade I to III hypertension with the third layer of risk factors according to the guidelines for the management of hypertension japanese society of hypertension(JSH)2009
- Chronic kidney disease(stage G3a or G3b) according ot the clinical Practice Guidebook for Diagnosis and Treatment of Chronic Kidney Disease 2012 in Japan
- History of coronary artery disease or noncardiogenic cerebral infarction
Exclusion
- Under 40 years of age or over 74 years of age
- An ankle-brachial index less than 0.9
- Chronic atrial fibrillation
- Current symptoms of heart failure(NYHA class III or IV) or left ventricular dysfunction (EF below 40%)
- Malignancy
- Chronic kidney disease(G4 or G5)according ot the clinical Practice Guidebook for Diagnosis and Treatment of Chronic Kidney Disease 2012 in Japan
- chronic dialysis due to renal failure
- Taking steroids/immunosuppressants
- Hepatocirrhosis
Key Trial Info
Start Date :
May 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2020
Estimated Enrollment :
3026 Patients enrolled
Trial Details
Trial ID
NCT01859897
Start Date
May 1 2013
End Date
April 1 2020
Last Update
September 25 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Okayama University
Okayama, Japan, 700-8558